RXRA and inflammatory response: In an early study, Desreumaux et al. showed a protective effect against colon inflammation through activation of the RXRα/PPARγ heterodimer and suggested that, based on their synergistic actions, the combination of RXRα and PPARγ ligands could be a promising therapeutic approach [29].